The NO/cGMP kinase pathway has prominent relaxing effects on contracted vascular smooth muscle. To elucidate to which extent Ca 2+ -desensitization is involved in this relaxation process, experiments were performed on permeabilized aortic preparation at constant [Ca 2+ ].
The NO/cGMP kinase pathway has prominent relaxing effects on contracted vascular smooth muscle. To elucidate to which extent Ca 2+ -desensitization is involved in this relaxation process, experiments were performed on permeabilized aortic preparation at constant [Ca 2+ ].
Both, 8-Br-cGMP (300 µM) and the Rho-kinase inhibitor Y-27632 (10 µM) relaxed contractions induced by pCa 6.5; the effects of both drugs were attenuated at higher [Ca 2+ ]. Interestingly, 8-Br-cGMP (300 µM) relaxed precontracted preparation from both wild type as well as from cGKI -/-mice by 78 and 58 %, respectively. Pre-treatment with the protein kinase A inhibitor peptide 5-24 reduced the 8-Br-cGMP-induced relaxation to 28 and 4 % in preparations from wild type and cGKI -/-mice, respectively. These results indicate that 8-Br-cGMP-induced Ca 2+ -desensitization is mostly mediated by protein kinase A in murine aorta.
Next, we studied the effects of 8-Br-cGMP on Ca 2+ -sensitization after stimulation of G-proteins with phenylephrine and GTP-γ-S at pCa 6.5. Phenylephrine (10 µM) did barely induce contraction at pCa 6.5, whereas GTP-γ-S initiated a strong additional contraction. In the presence of the protein kinase A inhibitor peptide 5-24, 8-Br-cGMP (300 µM) relaxed phenylephrine-induced contractions to 40 and 5% in wild type and cGKI -/-murine aorta, respectively. After stimulation with GTP-α-S, 8-Br-cGMP relaxed the aortic rings to about 5% in wild type, whereas Y-27632 (10 µM) induced a relaxation to about 50%.
These results show that 8-Br-cGMP-induced Ca 2+ -desensitization is mediated by protein kinase A and cGKI. Activation of G-proteins by GTP-γ-S abolished the relaxant effect of 8-Br-cGMP but not that of the Rho-kinase inhibitor Y-27632 in murine aorta.
